FDA Approved: URSODIOL — Supplemental Application (Lannett Company, Inc.)

View source ↗

Summary

FDA approved a supplemental application for ursodiol (ursodeoxycholic acid) from Lannett Company, Inc., adding changes to the existing approval under an ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Cholangitis
• Gallstone Disease

Drugs mentioned

• URSODIOL (ursodiol)

Snippet

SUPPL AP for URSODIOL (URSODIOL)